Home News

News - Page 1493

GILD Stock Dips by 2.15%, Despite Reporting Profitable Q3 Earnings
By • 3 mins read
Business News, Market News, News

GILD Stock Dips by 2.15%, Despite Reporting Profitable Q3 Earnings

By • 3 mins read

Gilead Sciences Inc, the American biopharmaceutical company behind the only approved drug for the treatment of COVID-19 known as Remdesivir (or Veklury) has released its third-quarter earnings in which the company posted better than expected earnings. Per the figures posted, GILD reported product sales of $6.5 billion, an 18% increment year-over-year.